Cargando…

Prognostic significance of HER2 status evaluation using immunohistochemistry in patients with urothelial carcinoma of the bladder: A retrospective single‑center experience

In recent years, antibody-drug conjugate (ADC) therapy targeting human epidermal growth factor receptor 2 (HER2) has been proven to be beneficial in patients with advanced urothelial carcinoma of the bladder (UCB); however, the role of HER2 in UCB remains obscure. Thus, the present retrospective sin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Xuesong, He, Weiyang, Yin, Hubin, Li, Xinyuan, Zhou, Xiang, Wei, Zongjie, Yu, Haitao, Gou, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622977/ https://www.ncbi.nlm.nih.gov/pubmed/36324611 http://dx.doi.org/10.3892/etm.2022.11640

Ejemplares similares

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients
por: Zhu, Xin, et al.
Publicado: (2020)

EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation
por: Yin, Hubin, et al.
Publicado: (2022)

β-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway
por: Gan, Daoju, et al.
Publicado: (2020)

Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma
por: Liu, Yu, et al.
Publicado: (2020)

Identification of a 13-mRNA signature for predicting disease progression and prognosis in patients with bladder cancer
por: Yin, Hubin, et al.
Publicado: (2020)

Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma
por: Yoo, Daeseon, et al.
Publicado: (2023)

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
por: Zhang, Chen, et al.
Publicado: (2020)

HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation
por: Yin, Hubin, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma
por: Jiang, Yuanbin, et al.
Publicado: (2020)

Bladder Cancer‐Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP‐Related Metabolic Reprogramming and SerRS O‐GlcNAcylation in Endothelial Cells
por: Li, Xinyuan, et al.
Publicado: (2022)

A Novel Prognostic Model Based on Autophagy-Related Long Non-Coding RNAs for Clear Cell Renal Cell Carcinoma
por: Li, Xinyuan, et al.
Publicado: (2021)

Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
por: Lim, So Dug, et al.
Publicado: (2015)

AB130. The expression and clinical significance of HIF-1α in bladder urothelial carcinoma
por: Fan, Haitao
Publicado: (2016)

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
por: Kim, Gilhyang, et al.
Publicado: (2016)

Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma
por: Lyu, Lei, et al.
Publicado: (2020)

Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer
por: Boström, Minna M., et al.
Publicado: (2015)

Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification
por: Zhang, Yu, et al.
Publicado: (2018)

Evaluation of the Expression of HER2 and c-KIT Proteins as Prognostic Markers in Superficial Bladder Urothelial Carcinoma
por: Abdou Hassan, Wael, et al.
Publicado: (2021)

Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues
por: Lu, Jiangli, et al.
Publicado: (2022)

Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma
por: Wang, Jiawu, et al.
Publicado: (2019)

Status of Her2 over expression in muscle invasive urothelial bladder carcinoma: Report of 21 cases
por: Mejri, Nesrine, et al.
Publicado: (2014)

Clinical Significance and Effect of MTDH/AEG-I in Bladder Urothelial Cancer: A Study Based on Immunohistochemistry, RNA-Seq, and in vitro Verification [Retraction]
Publicado: (2020)

Angiogenesis related gene expression significantly associated with the prognostic role of an urothelial bladder carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2020)

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
por: Tschui, J., et al.
Publicado: (2015)

A novel risk score model based on five angiogenesis-related long non-coding RNAs for bladder urothelial carcinoma
por: Li, Xinyuan, et al.
Publicado: (2022)

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder
por: Minato, Akinori, et al.
Publicado: (2018)

Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications
por: Zhu, Gongmin, et al.
Publicado: (2019)

Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014)

Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
por: Kim, Donghyun, et al.
Publicado: (2020)

Survivin and Her2 Expressions in Different Grades of Urothelial Neoplasms of Urinary Bladder
por: Moradi Tabriz, Hedieh, et al.
Publicado: (2021)

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma
por: Ponnaboina, Divya Madhuri, et al.
Publicado: (2023)

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder
por: hashmi, Atif Ali, et al.
Publicado: (2018)

The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients
por: Salah Fararjeh, AbdulFattah, et al.
Publicado: (2021)

Prognostic Significance of PD-L2 Expression in Association with Neutrophil-to-Lymphocyte Ratio in Urothelial Carcinoma of the Bladder
por: Hendri, Ahmad Zulfan, et al.
Publicado: (2023)

Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
por: Wei, Zongjie, et al.
Publicado: (2022)

Independent prognostic miRNAs for bladder urothelial carcinoma
por: Hu, Yingbo, et al.
Publicado: (2017)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

Is HER2 amplification predictable by digital immunohistochemistry?
por: Micsik, Tamás, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l3cemb4ipe605jvl5i61dlsrt2